Not provided
Not provided
Not provided
Not provided
Not provided
Lack of adherence and huge loss of follow up.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Sao Paulo | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to evaluate the therapeutic effect of the infusion of Maytenus ilicifolia Mart. ex Reiss leaves, used for 8 weeks, on patients with dyspepsia. Primary endpoint is SODA score, secondary endpoint is endoscopic classification (Sydney).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Maytenus | Experimental | Tea of Martens ilicifolia leaves |
|
| Omeprazole | Active Comparator | Omeprazole as active comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Maytenus ilicifolia leaves infusion | Drug | 2 g of powdered leaves in 150 mL of boiling water, 3 times a day, for 8 weeks |
|
| Measure | Description | Time Frame |
|---|---|---|
| SODA score | 8 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Sydney classification | 8 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ana MS Pereira, PhD | University of Ribeirao Preto | Study Director |
| Jose S Santos, MD, PhD | HCFMRP-USP | Study Chair |
| Fabio Carmona, MD, PhD | HCFMRP-USP | Principal Investigator |
| Suzeidi B Castanheira, MD, PhD | HCFMRP-USP | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital das Clinicas FMRP-USP | Ribeirão Preto | São Paulo | 14049-900 | Brazil |
Not provided
| ID | Term |
|---|---|
| D004415 | Dyspepsia |
| ID | Term |
|---|---|
| D012817 | Signs and Symptoms, Digestive |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D009853 | Omeprazole |
| ID | Term |
|---|---|
| D053799 | 2-Pyridinylmethylsulfinylbenzimidazoles |
| D013454 | Sulfoxides |
| D013457 | Sulfur Compounds |
| D009930 | Organic Chemicals |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Omeprazole | Drug | Standard therapy |
|
| D011725 |
| Pyridines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
| D001562 | Benzimidazoles |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |